Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 24.0B | 23.0B | 21.8B | 20.4B |
Cost of revenue | 4.1B | 4.4B | 4.3B | 3.9B |
Gross profit | 19.9B | 18.6B | 17.6B | 16.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.3B | 3.1B | 2.7B | 2.7B |
Operating income | 25.8B | 16.1B | 14.7B | 13.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 14.2B | 13.6B | 13.1B | 12.0B |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 906.9M | 1.9B | 2.5B |
Tax provision | 136.3M | 521.3M | 272.3M | 664.5M |
Net income | 1.0B | 385.6M | 1.6B | 1.8B |
Basic EPS | — | 1.7 | 7.2 | 8.1 |
Diluted EPS | — | 1.7 | 7.2 | 8.0 |
Basic average shares | — | 225.5M | 225.4M | 224.6M |
Diluted average shares | — | 228.2M | 227.9M | 226.6M |
EBITDA | 29.5B | 17.6B | 17.1B | 14.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |